<DOC>
	<DOCNO>NCT00048815</DOCNO>
	<brief_summary>This 6-month study compare effectiveness citalopram ( CelexaÂ® ) , hypericum ( St. John 's Wort ) , placebo treatment minor depression .</brief_summary>
	<brief_title>Drug Therapy Treat Minor Depression</brief_title>
	<detailed_description>Minor depression highly prevalent , cause substantial morbidity disability , present serious risk factor development major depressive disorder , yet recognize treat . Researchers determine patient minor depression frequently seek treatment general practitioner often treat prescription antidepressant . There need evaluate effectiveness St. John 's Wort management minor depression . If propose study demonstrate efficacy St. John 's Wort and/or citalopram , suggest treatment paradigm test applied primary care setting . Patients meet screen criterion enter 2-week washout period ( , fluoxetine , 4-week washout period ) psychotropic medication permit . Participants randomly assign St. John 's Wort , citalopram , placebo 12 week . Participants respond treatment Week 12 continue take originally assign double-blind medication 26 week . At Week 12 , nonresponders placebo cross 1 2 active treatment . Patients remain nonresponders active treatment cross alternative active treatment , investigator maintain blind status . Participants study visit screen , washout period , baseline , every 2 week thereafter course study . At screen visit , Week 12 , Week 20 , patient undergo complete blood count differential routine laboratory test .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<criteria>Minor Depression symptom least 6 month Endorse one DSMIV `` A '' criterion MDD least one symptom MDD endorse `` A '' criterion MDD Global Assessment Functioning ( GAF ) score &lt; 70 Short form health survey ( SF36 ) social function score &lt; = 75 % emotional role function score &lt; = 67 % HAMD17 score 1017 , inclusive Minor depression symptom least 6 month Major depressive disorder ( MDD ) dysthymia within past year partial remission MDD At least 12week course either citalopram minimum 40 mg/day St. John 's Wort minimum 900 mg/day current episode depression Previous intolerance either citalopram St. John 's Wort history nonresponse either citalopram minimum 40 mg/day St. John 's Wort minimum 900 mg/day least 12 week Unstable medical illness , include cardiovascular , hepatic , renal , respiratory , endocrine , neurologic , hematologic disease Uncontrolled seizure disorder The following DSMIV diagnosis : organic mental disorder ; substance use disorder , include alcohol , active within last year patient positive urine drug screen ; schizophrenia ; delusional disorder ; psychotic disorder elsewhere classify ; bipolar disorder ; bereavement ; adjustment disorder ; antisocial personality disorder ; panic disorder , social phobia , generalize anxiety disorder ( GAD ) , obsessive compulsive disorder ( OCD ) . Patients may lifetime diagnosis anxiety disorder long current . Moodcongruent moodincongruent psychotic feature Psychotropic drug Hypothyroidism Investigational psychotropic drug within last year Positive toxicology screen Medications metabolize CYP3A4 system , induction system pose risk medical stability patient Pregnancy refusal use medically accept method contraception Serious suicide homicide risk Psychotherapy begin less 3 month ago</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>